CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The S&P/ASX 200 (INDEXASX:XJO) is set to rise when (or if) the market opens this morning. ASX (ASX:ASX), CSL (ASX:CSL) and Zip (ASX:Z1P) shares are in the news.
CSL Limited (ASX:CSL) is in the news this morning after news broke of a new manufacturing centre.
The S&P/ASX 200 (ASX: XJO) is expected to open higher on Monday morning, according to data from the Sydney Futures Exchange.
The S&P/ASX 200 (INDEXASX:XJO) is expected to follow a strong lead from US markets and open higher on Friday. NAB (ASX:NAB) and Scentre (ASX:SCG) shares are in the news.
The S&P/ASX 200 (INDEXASX:XJO) is expected to slide when the market opens this morning. Ampol Ltd (ASX:ALD) and Cimic Group (ASX:CIM) shares are in the news.
The CSL Limited (ASX:CSL) share price is up after the healthcare company improved its FY21 profit expectations.
CSL Limited (ASX:CSL) has continued to be in the top 20 traded shares on the ASX recently. The COVID-19 vaccine deal looks promising, is it time to buy shares?
CSL Limited (ASX:CSL) has signed an agreement with the Australian government for a COVID-19 vaccine.
Share buy-backs have been used by many companies on the S&P/ASX 200 (INDEXASX:XJO), including Woolworths Group Ltd (ASX: WOW) and CSL Limited (ASX: CSL).
